BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36859258)

  • 1. High variability of COVID-19 case fatality rate in Germany.
    Wjst M; Wendtner C
    BMC Public Health; 2023 Mar; 23(1):416. PubMed ID: 36859258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.
    Staerk C; Wistuba T; Mayr A
    BMC Public Health; 2021 Jun; 21(1):1073. PubMed ID: 34090392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality.
    Dudel C; Riffe T; Acosta E; van Raalte A; Strozza C; Myrskylä M
    PLoS One; 2020; 15(9):e0238904. PubMed ID: 32913365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.
    Zhou C; Wheelock ÅM; Zhang C; Ma J; Dong K; Pan J; Li Z; Liang W; Gao J; Xu L
    Front Public Health; 2023; 11():1150095. PubMed ID: 37143970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany.
    Sagoschen I; Keller K; Wild J; Münzel T; Hobohm L
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423124
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Salyer SJ; Maeda J; Sembuche S; Kebede Y; Tshangela A; Moussif M; Ihekweazu C; Mayet N; Abate E; Ouma AO; Nkengasong J
    Lancet; 2021 Apr; 397(10281):1265-1275. PubMed ID: 33773118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample.
    Hobohm L; Sagoschen I; Barco S; Schmidtmann I; Espinola-Klein C; Konstantinides S; Münzel T; Keller K
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The age structure of cases as the key of COVID-19 severity: Longitudinal population-based analysis of European countries during 150 days.
    Hulíková Tesárková K; Dzúrová D
    Scand J Public Health; 2022 Aug; 50(6):738-747. PubMed ID: 34923870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Mortality and Respiratory Support in Elderly Patients Hospitalized with COVID-19 in Korea.
    Lee JY; Kim HA; Huh K; Hyun M; Rhee JY; Jang S; Kim JY; Peck KR; Chang HH
    J Korean Med Sci; 2020 Jun; 35(23):e223. PubMed ID: 32537957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].
    Zhao Z; Cao H; Cheng Q; Li N; Zhang S; Ge Q; Shen N; Yang L; Shi W; Bai J; Meng Q; Wu C; Wang B; Li Q; Yao G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):708-713. PubMed ID: 34296691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality among adult hospitalized patients during the first wave and second wave of COVID-19 pandemic at a tertiary care center in India.
    Nath R; Gupta NK; Jaswal A; Gupta S; Kaur N; Kohli S; Saxena A; Ish P; Kumar R; Tiwari P; Kumar M; Kishore J; Yadav G; Marwein F; Gupta N
    Monaldi Arch Chest Dis; 2021 Oct; 92(2):. PubMed ID: 34634900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
    Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
    Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Spatial analysis of hospital case-fatality rate in France.
    Souris M; Gonzalez JP
    PLoS One; 2020; 15(12):e0243606. PubMed ID: 33320895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological comparison of the first and second waves of the COVID-19 pandemic in Nigeria, February 2020-April 2021.
    Akande OW; Elimian KO; Igumbor E; Dunkwu L; Kaduru C; Olopha OO; Ohanu DO; Nwozor L; Agogo E; Aruna O; Balogun MS; Aderinola O; Ahumibe A; Arinze C; Badaru SO; Nwachukwu W; Dada AO; Erameh C; Hamza K; Mohammed TB; Ndodo N; Obiekea C; Ofoegbunam C; Ogunbode O; Ohonsi C; Tobin EA; Yashe R; Adekaiyaoja A; Asuzu MC; Audu RA; Bello MB; Bello SO; Deeni YY; Disu Y; Joseph G; Ezeokafor C; Habib ZG; Ibeh C; Ike IF; Iwara E; Luka-Lawal RK; Namara G; Okwor T; Olajide L; Ilesanmi OO; Omonigho S; Oyiri F; Takpa K; Ugbogulu NU; Ibekwe P; Oladejo J; Ilori E; Ochu CL; Ihekweazu C
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34794956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study.
    Nachtigall I; Lenga P; Jóźwiak K; Thürmann P; Meier-Hellmann A; Kuhlen R; Brederlau J; Bauer T; Tebbenjohanns J; Schwegmann K; Hauptmann M; Dengler J
    Clin Microbiol Infect; 2020 Dec; 26(12):1663-1669. PubMed ID: 32822883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.